Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

Overview of attention for article published in Frontiers in oncology, February 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Altmetric has seen 6 X posts from 4 X users, with an upper bound of 7,675 followers.

RT @FrontOncology: New research: Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells: Novel therapeutic st…

RT @FrontOncology: New research: Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells: Novel therapeutic st…

RT @FrontOncology: 📣 Original article: Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant #ProstateCancer Cells 👨‍⚕️👩‍⚕️ Vakhr…

📣 Original article: Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant #ProstateCancer Cells 👨‍⚕️👩‍⚕️ Vakhrusheva O et al Read here 👉 https://t.co/0ULMNnVVe1 @MartMichaelis @AxelHaferkanp #Oncology #Pharmacology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.